img

Global and United States Influenza A Vaccine Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Influenza A Vaccine Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Influenza A Vaccine Market
This report focuses on global and United States Influenza A Vaccine market, also covers the segmentation data of other regions in regional level and county level.
The global Influenza A Vaccine revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In United States the Influenza A Vaccine revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Influenza A Vaccine include Novartis, Sanofi, GSK, Medimmune, Abbott, Mitsubishi Tanabe Pharma, Merck, Sinovac Biotech and Hualan Biological Engineering, etc. The global five biggest players hold a share of % in 2024.
Global Influenza A Vaccine Scope and Market Size
Influenza A Vaccine market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Influenza A Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Influenza A Vaccine market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Novartis
Sanofi
GSK
Medimmune
Abbott
Mitsubishi Tanabe Pharma
Merck
Sinovac Biotech
Hualan Biological Engineering
Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Segment by Type
Intramuscular Vaccine
Nasal Spray Vaccine

Segment by Application


3-18 Years Old
Above 18 Years Old
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Influenza A Vaccine definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Influenza A Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Influenza A Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza A Vaccine sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Influenza A Vaccine Product Introduction
1.2 Global Influenza A Vaccine Outlook 2018 VS 2024 VS 2034
1.2.1 Global Influenza A Vaccine Sales in US$ Million for the Year 2018-2034
1.2.2 Global Influenza A Vaccine Sales in Volume for the Year 2018-2034
1.3 United States Influenza A Vaccine Outlook 2018 VS 2024 VS 2034
1.3.1 United States Influenza A Vaccine Sales in US$ Million for the Year 2018-2034
1.3.2 United States Influenza A Vaccine Sales in Volume for the Year 2018-2034
1.4 Influenza A Vaccine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Influenza A Vaccine in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Influenza A Vaccine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Influenza A Vaccine Market Dynamics
1.5.1 Influenza A Vaccine Industry Trends
1.5.2 Influenza A Vaccine Market Drivers
1.5.3 Influenza A Vaccine Market Challenges
1.5.4 Influenza A Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Influenza A Vaccine by Type
2.1 Influenza A Vaccine Market Segment by Type
2.1.1 Intramuscular Vaccine
2.1.2 Nasal Spray Vaccine
2.2 Global Influenza A Vaccine Market Size by Type
2.2.1 Global Influenza A Vaccine Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Influenza A Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Influenza A Vaccine Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Influenza A Vaccine Market Size by Type
2.3.1 United States Influenza A Vaccine Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Influenza A Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Influenza A Vaccine Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Influenza A Vaccine by Application
3.1 Influenza A Vaccine Market Segment by Application
3.1.1 3-18 Years Old
3.1.2 Above 18 Years Old
3.2 Global Influenza A Vaccine Market Size by Application
3.2.1 Global Influenza A Vaccine Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Influenza A Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Influenza A Vaccine Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Influenza A Vaccine Market Size by Application
3.3.1 United States Influenza A Vaccine Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Influenza A Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Influenza A Vaccine Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Influenza A Vaccine Competitor Landscape by Company
4.1 Global Influenza A Vaccine Market Size by Company
4.1.1 Global Key Manufacturers of Influenza A Vaccine, Ranked by Revenue (2024)
4.1.2 Global Influenza A Vaccine Revenue by Manufacturer (2018-2023)
4.1.3 Global Influenza A Vaccine Sales by Manufacturer (2018-2023)
4.1.4 Global Influenza A Vaccine Price by Manufacturer (2018-2023)
4.2 Global Influenza A Vaccine Concentration Ratio (CR)
4.2.1 Influenza A Vaccine Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Influenza A Vaccine in 2024
4.2.3 Global Influenza A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Influenza A Vaccine, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Influenza A Vaccine, Product Offered and Application
4.5 Global Key Manufacturers of Influenza A Vaccine, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Influenza A Vaccine Market Size by Company
4.7.1 Key Players of Influenza A Vaccine in United States, Ranked by Revenue (2024)
4.7.2 United States Influenza A Vaccine Revenue by Players (2018-2023)
4.7.3 United States Influenza A Vaccine Sales by Players (2018-2023)
5 Global Influenza A Vaccine Market Size by Region
5.1 Global Influenza A Vaccine Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Influenza A Vaccine Market Size in Volume by Region (2018-2034)
5.2.1 Global Influenza A Vaccine Sales in Volume by Region: 2018-2023
5.2.2 Global Influenza A Vaccine Sales in Volume Forecast by Region (2024-2034)
5.3 Global Influenza A Vaccine Market Size in Value by Region (2018-2034)
5.3.1 Global Influenza A Vaccine Sales in Value by Region: 2018-2023
5.3.2 Global Influenza A Vaccine Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Influenza A Vaccine Market Size YoY Growth 2018-2034
6.2 Americas Influenza A Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Influenza A Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Influenza A Vaccine Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Influenza A Vaccine Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Influenza A Vaccine Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Influenza A Vaccine Market Size YoY Growth 2018-2034
7.2 EMEA Influenza A Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Influenza A Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Influenza A Vaccine Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Influenza A Vaccine Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Influenza A Vaccine Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Influenza A Vaccine Market Size YoY Growth 2018-2034
8.2 China Influenza A Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Influenza A Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Influenza A Vaccine Market Size YoY Growth 2018-2034
9.2 APAC Influenza A Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Influenza A Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Influenza A Vaccine Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Influenza A Vaccine Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Influenza A Vaccine Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Description and Business Overview
10.1.3 Novartis Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Influenza A Vaccine Products Offered
10.1.5 Novartis Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Description and Business Overview
10.2.3 Sanofi Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Influenza A Vaccine Products Offered
10.2.5 Sanofi Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Description and Business Overview
10.3.3 GSK Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GSK Influenza A Vaccine Products Offered
10.3.5 GSK Recent Development
10.4 Medimmune
10.4.1 Medimmune Company Information
10.4.2 Medimmune Description and Business Overview
10.4.3 Medimmune Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Medimmune Influenza A Vaccine Products Offered
10.4.5 Medimmune Recent Development
10.5 Abbott
10.5.1 Abbott Company Information
10.5.2 Abbott Description and Business Overview
10.5.3 Abbott Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Abbott Influenza A Vaccine Products Offered
10.5.5 Abbott Recent Development
10.6 Mitsubishi Tanabe Pharma
10.6.1 Mitsubishi Tanabe Pharma Company Information
10.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
10.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Products Offered
10.6.5 Mitsubishi Tanabe Pharma Recent Development
10.7 Merck
10.7.1 Merck Company Information
10.7.2 Merck Description and Business Overview
10.7.3 Merck Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck Influenza A Vaccine Products Offered
10.7.5 Merck Recent Development
10.8 Sinovac Biotech
10.8.1 Sinovac Biotech Company Information
10.8.2 Sinovac Biotech Description and Business Overview
10.8.3 Sinovac Biotech Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sinovac Biotech Influenza A Vaccine Products Offered
10.8.5 Sinovac Biotech Recent Development
10.9 Hualan Biological Engineering
10.9.1 Hualan Biological Engineering Company Information
10.9.2 Hualan Biological Engineering Description and Business Overview
10.9.3 Hualan Biological Engineering Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Hualan Biological Engineering Influenza A Vaccine Products Offered
10.9.5 Hualan Biological Engineering Recent Development
10.10 Changsheng Bio-Technology
10.10.1 Changsheng Bio-Technology Company Information
10.10.2 Changsheng Bio-Technology Description and Business Overview
10.10.3 Changsheng Bio-Technology Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Changsheng Bio-Technology Influenza A Vaccine Products Offered
10.10.5 Changsheng Bio-Technology Recent Development
10.11 Beijing Tiantan Bio-Products
10.11.1 Beijing Tiantan Bio-Products Company Information
10.11.2 Beijing Tiantan Bio-Products Description and Business Overview
10.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Beijing Tiantan Bio-Products Influenza A Vaccine Products Offered
10.11.5 Beijing Tiantan Bio-Products Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Influenza A Vaccine Industry Chain Analysis
11.2 Influenza A Vaccine Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Influenza A Vaccine Production Mode & Process
11.4 Influenza A Vaccine Sales and Marketing
11.4.1 Influenza A Vaccine Sales Channels
11.4.2 Influenza A Vaccine Distributors
11.5 Influenza A Vaccine Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Influenza A Vaccine CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Influenza A Vaccine Market Trends
Table 3. Influenza A Vaccine Market Drivers
Table 4. Influenza A Vaccine Market Challenges
Table 5. Influenza A Vaccine Market Restraints
Table 6. Global Influenza A Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Influenza A Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Influenza A Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Influenza A Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Influenza A Vaccine, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Influenza A Vaccine Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Influenza A Vaccine Revenue Share by Manufacturer, 2018-2023
Table 13. Global Influenza A Vaccine Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Influenza A Vaccine Sales Share by Manufacturer, 2018-2023
Table 15. Global Influenza A Vaccine Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Influenza A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Influenza A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza A Vaccine as of 2024)
Table 18. Global Key Manufacturers of Influenza A Vaccine, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Influenza A Vaccine, Product Offered and Application
Table 20. Global Key Manufacturers of Influenza A Vaccine, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Influenza A Vaccine in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Influenza A Vaccine Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Influenza A Vaccine Revenue Share by Players, (2018-2023)
Table 25. United States Influenza A Vaccine Sales by Players, (K Units), (2018-2023)
Table 26. United States Influenza A Vaccine Sales Share by Players, (2018-2023)
Table 27. Global Influenza A Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Influenza A Vaccine Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Influenza A Vaccine Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Influenza A Vaccine Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Influenza A Vaccine Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Influenza A Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Influenza A Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Influenza A Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Influenza A Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Influenza A Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Influenza A Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Influenza A Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Influenza A Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Influenza A Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Influenza A Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Influenza A Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Influenza A Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Novartis Company Information
Table 48. Novartis Description and Business Overview
Table 49. Novartis Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Novartis Influenza A Vaccine Product
Table 51. Novartis Recent Development
Table 52. Sanofi Company Information
Table 53. Sanofi Description and Business Overview
Table 54. Sanofi Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Sanofi Influenza A Vaccine Product
Table 56. Sanofi Recent Development
Table 57. GSK Company Information
Table 58. GSK Description and Business Overview
Table 59. GSK Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. GSK Influenza A Vaccine Product
Table 61. GSK Recent Development
Table 62. Medimmune Company Information
Table 63. Medimmune Description and Business Overview
Table 64. Medimmune Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Medimmune Influenza A Vaccine Product
Table 66. Medimmune Recent Development
Table 67. Abbott Company Information
Table 68. Abbott Description and Business Overview
Table 69. Abbott Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Abbott Influenza A Vaccine Product
Table 71. Abbott Recent Development
Table 72. Mitsubishi Tanabe Pharma Company Information
Table 73. Mitsubishi Tanabe Pharma Description and Business Overview
Table 74. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Mitsubishi Tanabe Pharma Influenza A Vaccine Product
Table 76. Mitsubishi Tanabe Pharma Recent Development
Table 77. Merck Company Information
Table 78. Merck Description and Business Overview
Table 79. Merck Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Merck Influenza A Vaccine Product
Table 81. Merck Recent Development
Table 82. Sinovac Biotech Company Information
Table 83. Sinovac Biotech Description and Business Overview
Table 84. Sinovac Biotech Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Sinovac Biotech Influenza A Vaccine Product
Table 86. Sinovac Biotech Recent Development
Table 87. Hualan Biological Engineering Company Information
Table 88. Hualan Biological Engineering Description and Business Overview
Table 89. Hualan Biological Engineering Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Hualan Biological Engineering Influenza A Vaccine Product
Table 91. Hualan Biological Engineering Recent Development
Table 92. Changsheng Bio-Technology Company Information
Table 93. Changsheng Bio-Technology Description and Business Overview
Table 94. Changsheng Bio-Technology Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Changsheng Bio-Technology Influenza A Vaccine Product
Table 96. Changsheng Bio-Technology Recent Development
Table 97. Beijing Tiantan Bio-Products Company Information
Table 98. Beijing Tiantan Bio-Products Description and Business Overview
Table 99. Beijing Tiantan Bio-Products Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Beijing Tiantan Bio-Products Influenza A Vaccine Product
Table 101. Beijing Tiantan Bio-Products Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Influenza A Vaccine Customers List
Table 105. Influenza A Vaccine Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza A Vaccine Product Picture
Figure 2. Global Influenza A Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Influenza A Vaccine Market Size 2018-2034 (US$ Million)
Figure 4. Global Influenza A Vaccine Sales 2018-2034 (K Units)
Figure 5. United States Influenza A Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Influenza A Vaccine Market Size 2018-2034 (US$ Million)
Figure 7. United States Influenza A Vaccine Sales 2018-2034 (K Units)
Figure 8. United States Influenza A Vaccine Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Influenza A Vaccine Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Influenza A Vaccine Report Years Considered
Figure 11. Product Picture of Intramuscular Vaccine
Figure 12. Product Picture of Nasal Spray Vaccine
Figure 13. Global Influenza A Vaccine Market Share by Type in 2024 & 2034
Figure 14. Global Influenza A Vaccine Sales in Value by Type (2018-2034) & (US$ Million)
Figure 15. Global Influenza A Vaccine Sales Market Share in Value by Type (2018-2034)
Figure 16. Global Influenza A Vaccine Sales by Type (2018-2034) & (K Units)
Figure 17. Global Influenza A Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 18. Global Influenza A Vaccine Price by Type (2018-2034) & (US$/Unit)
Figure 19. United States Influenza A Vaccine Market Share by Type in 2024 & 2034
Figure 20. United States Influenza A Vaccine Sales in Value by Type (2018-2034) & (US$ Million)
Figure 21. United States Influenza A Vaccine Sales Market Share in Value by Type (2018-2034)
Figure 22. United States Influenza A Vaccine Sales by Type (2018-2034) & (K Units)
Figure 23. United States Influenza A Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 24. United States Influenza A Vaccine Price by Type (2018-2034) & (US$/Unit)
Figure 25. Product Picture of 3-18 Years Old
Figure 26. Product Picture of Above 18 Years Old
Figure 27. Global Influenza A Vaccine Market Share by Application in 2024 & 2034
Figure 28. Global Influenza A Vaccine Sales in Value by Application (2018-2034) & (US$ Million)
Figure 29. Global Influenza A Vaccine Sales Market Share in Value by Application (2018-2034)
Figure 30. Global Influenza A Vaccine Sales by Application (2018-2034) & (K Units)
Figure 31. Global Influenza A Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 32. Global Influenza A Vaccine Price by Application (2018-2034) & (US$/Unit)
Figure 33. United States Influenza A Vaccine Market Share by Application in 2024 & 2034
Figure 34. United States Influenza A Vaccine Sales in Value by Application (2018-2034) & (US$ Million)
Figure 35. United States Influenza A Vaccine Sales Market Share in Value by Application (2018-2034)
Figure 36. United States Influenza A Vaccine Sales by Application (2018-2034) & (K Units)
Figure 37. United States Influenza A Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 38. United States Influenza A Vaccine Price by Application (2018-2034) & (US$/Unit)
Figure 39. Americas Influenza A Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 40. Americas Influenza A Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 41. Americas Influenza A Vaccine Sales by Type (2018-2034) & (K Units)
Figure 42. Americas Influenza A Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 43. Americas Influenza A Vaccine Sales by Application (2018-2034) & (K Units)
Figure 44. Americas Influenza A Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 45. United States Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 46. Canada Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Mexico Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Brazil Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. EMEA Influenza A Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 50. EMEA Influenza A Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 51. EMEA Influenza A Vaccine Sales by Type (2018-2034) & (K Units)
Figure 52. EMEA Influenza A Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 53. EMEA Influenza A Vaccine Sales by Application (2018-2034) & (K Units)
Figure 54. EMEA Influenza A Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 55. Europe Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 56. Middle East Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Africa Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. China Influenza A Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 59. China Influenza A Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 60. China Influenza A Vaccine Sales by Type (2018-2034) & (K Units)
Figure 61. China Influenza A Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 62. China Influenza A Vaccine Sales by Application (2018-2034) & (K Units)
Figure 63. China Influenza A Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 64. APAC Influenza A Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 65. APAC Influenza A Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 66. APAC Influenza A Vaccine Sales by Type (2018-2034) & (K Units)
Figure 67. APAC Influenza A Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 68. APAC Influenza A Vaccine Sales by Application (2018-2034) & (K Units)
Figure 69. APAC Influenza A Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 70. Japan Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 71. South Korea Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. China Taiwan Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. Southeast Asia Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. India Influenza A Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. Influenza A Vaccine Value Chain
Figure 76. Influenza A Vaccine Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries